Abbott Laboratories (ABT) Shares Repurchased (2009 - 2026)

Abbott Laboratories has disclosed Shares Repurchased across 18 years of filings, most recently posting $180.0 million for Q1 2026.

• Shares Repurchased for Q1 2026 came in at $180.0 million, down 35.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $793.0 million (down 41.22% YoY), and the FY2025 annual result was $893.0 million, down 31.04% from the prior year.
• Shares Repurchased came in at $180.0 million for Q1 2026 at Abbott Laboratories, down from $302.0 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $2.3 billion in Q1 2022 to a low of $2.0 million in Q3 2023.
• The 5-year median for Shares Repurchased is $302.0 million (2025), against an average of $434.7 million.
• Across the five-year window, Shares Repurchased tumbled 99.75% in 2023 and surged 37450.0% in 2024, its largest moves.
• Abbott Laboratories' Shares Repurchased stood at $685.0 million in 2022, then plunged by 62.19% to $259.0 million in 2023, then increased by 21.62% to $315.0 million in 2024, then dropped by 4.13% to $302.0 million in 2025, then sank by 40.4% to $180.0 million in 2026.
• The last three Shares Repurchased figures came in at $180.0 million (Q1 2026), $302.0 million (Q4 2025), and $305.0 million (Q3 2025), per Business Quant data.